Cell and gene therapy tout promising results, but manufacturing challenges around personalized treatments require industry ...
According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...
The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.
Cancer Center's lymphoma specialist, Dr. Palomba, provides an in-depth look at how CAR T-cell therapy is evolving to offer ...
PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion ...
Charles River expanded the Memphis facility in November 2022, adding nine processing suites to its 16 clean rooms at the site ...
GlobalData on MSN7d
SmartCella gains rights to advance cell therapy research for Parkinson’sThe company signed the agreement with Karolinska Institutet's Department of Cell and Molecular Biology professor Johan ...
C3i obtained a Drug Establishment License (DEL) to produce cell therapies for patients across Canada commercially.
Cellistic, a pioneer in iPSC-based off-the-shelf cell therapy development and manufacturing services, announces the launch of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback